alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

112TH CONGRESS 

1ST SESSION S. 597 

To amend title XVIII of the Social Security Act to include neurologists 

as primary care physicians for purposes of incentive payments for primary care services under the Medicare program. 

IN THE SENATE OF THE UNITED STATES 

MARCH 16, 2011 

Ms. KLOBUCHAR (for herself and Ms. COLLINS) introduced the following bill; 

which was read twice and referred to the Committee on Finance 

A BILL 

To amend title XVIII of the Social Security Act to include 

neurologists as primary care physicians for purposes of 

incentive payments for primary care services under the 

Medicare program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MEDICARE PRIMARY CARE INCENTIVE PAY4 MENTS FOR NEUROLOGISTS. 

5 (a) MEDICARE.—Section 1833(x)(2)(A)(i)(I) of the 

6 Social Security Act (42 U.S.C. 1395l(x)(2)(A)(i)(I)) is 

7 amended by striking ‘‘or pediatric medicine’’ and inserting 

8 ‘‘pediatric medicine, or neurology’’. 


rfrederick on DSKD9S0YB1PROD with BILLS
2 

•S 597 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) shall apply as if included in the enactment 

3 of Public Law 111–148. 

Æ 


rfrederick on DSKD9S0YB1PROD with BILLS
# Europos Sąjungos C 134I/2022

| | ISSN 1977-0960 |
| --- | --- |
| Europos Sąjungos
  oficialusis leidinys | C 134I |
| | |
| Leidimas lietuvių kalba | Informacija ir pranešimai | 65 metai2022m. kovo 25d. |

ISSN 1977-0960

Europos Sąjungos

oficialusis leidinys

C 134I

Leidimas lietuvių kalba

Informacija ir pranešimai

65 metai2022m. kovo 25d.

---

| Turinys | Puslapis |
| --- | --- |
| | IV   Pranešimai |
| | EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI |
| | Europos Komisija |
| 2022/C 134 I/01 | Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka 2022 m. kovo 25 d.
  (Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004
  13 straipsnį arba 38 straipsnį) | 1 |

Turinys

Puslapis

IV   Pranešimai

EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI

Europos Komisija

2022/C 134 I/01

Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka 2022 m. kovo 25 d.
  (Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004
  13 straipsnį arba 38 straipsnį)

(Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004

13 straipsnį arba 38 straipsnį)

1

---

| LT | |
| --- | --- |

LT

---

IV Pranešimai

EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI

Europos Komisija

| 2022 3 25 | LT | Europos Sąjungos oficialusis leidinys | CI 134/1 |
| --- | --- | --- | --- |

2022 3 25

LT

Europos Sąjungos oficialusis leidinys

CI 134/1

---

Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka 2022 m. kovo 25 d.

(Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 (1)
  13 straipsnį arba 38 straipsnį)

(2022/C 134 I/01)

| — | Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta













  Sprendimo data | Vaisto pavadinimas | INN (Tarptautinis nepatentuotas pavadinimas) | Rinkodaros leidimo turėtojas | Įrašo numeris Bendrijos vaistų registre | Farmacinė forma | ATC kodas (Anatominis terapinis cheminis kodas) | Pranešimo data |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2022 3 25 | EVUSHELD | tiksagevimabas / cilgavimabas | AstraZeneca AB
  151 85 Södertälje, Sverige | EU/1/22/1651 | Injekcinis tirpalas | J06BD03 | 2022 3 25 |

—

Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta

Sprendimo data

Vaisto pavadinimas

INN (Tarptautinis nepatentuotas pavadinimas)

Rinkodaros leidimo turėtojas

Įrašo numeris Bendrijos vaistų registre

Farmacinė forma

ATC kodas (Anatominis terapinis cheminis kodas)

Pranešimo data

2022 3 25

EVUSHELD

tiksagevimabas / cilgavimabas

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/22/1651

Injekcinis tirpalas

J06BD03

2022 3 25

Norintieji susipažinti su nagrinėjamųjų vaistų vieša vertinimo ataskaita ir su ja susijusiais sprendimais, gali kreiptis į:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  OL L 136, 2004 4 30, p. 1.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### National Oceanic and Atmospheric Administration

          - [RTID 0648-XB225]

# AGENCY:

National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

# ACTION:

Notice; public meeting.

# SUMMARY:

The Mid-Atlantic Fishery Management Council's Mackerel, Squid, and Butterfish (MSB) Monitoring Committee will hold a public meeting.

# DATES:

                        The meeting will be held on Monday, July 26, 2021; from 10 a.m. to 1 p.m. For agenda details, see                         **SUPPLEMENTARY INFORMATION**                        .                    

# ADDRESSES:

                        The meeting will be held via webinar. Webinar connection information will be available at                         *www.mafmc.org/​council-events.*

*Council address:*                         Mid-Atlantic Fishery Management Council, 800 N State Street, Suite 201, Dover, DE 19901; telephone: (302) 674-2331;                         *www.mafmc.org.*

# FOR FURTHER INFORMATION CONTACT:

Christopher M. Moore, Ph.D., Executive Director, Mid-Atlantic Fishery Management Council, telephone: (302) 526-5255.

# SUPPLEMENTARY INFORMATION:

The purpose of the meeting is for the MSB Monitoring Committee to provide recommendations regarding Atlantic mackerel, potentially including: 2021/2022 emergency action, future specifications, and/or rebuilding plan modifications and options.

## Special Accommodations

The meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to Kathy Collins at the Council Office, (302) 526-5253, at least 5 days prior to the meeting date.

Authority: 16 U.S.C. 1801*et seq.*

Dated: July 7, 2021.

Tracey L. Thompson,

Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service.

[FR Doc. 2021-14782 Filed 7-14-21; 8:45 am]

BILLING CODE 3510-22-P
EXHIBIT 32.1



Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the Quarterly Report on Form 10-Q of AMCORE Financial, Inc. (the Company) for the quarterly period ended June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), Kenneth E. Edge, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of his knowledge:



(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                                       
|-------------------------------------------------------
|/s/ Kenneth E. Edge                                    
|Kenneth E. Edge Chief Executive
Officer August 11, 2003



This certification accompanies the
Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended.



A signed original of this written statement required by § 906 of
the Sarbanes-Oxley Act of 2002 has been provided to AMCORE Financial, Inc. and will be retained by AMCORE Financial, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
#### SMITH, Respondent, v. RUBEL, Appellant.

(Supreme Court, Appellate Division, First Department.

March 22, 1912.)

Action by Robert S. Smith against Max Rubel. D. C. Hirsch, for appellant. H. Nathan, for respondent. No opinion. Order affirmed, with §10 costs and disbursements. Order filed. See, also, 134 N. *Y.*Supp. 400.
Exhibit 32

Written Statement of Chief Executive Officer and Chief Financial Officer  Pursuant to Section 906  of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Regal Entertainment Group, a Delaware corporation (the "Company"), each hereby
certifies that, to his/her knowledge on the date hereof:



| |  | /s/MICHAEL L. CAMPBELLMichael L. Campbell
Chief Executive Officer
March 26, 2008
| |  | --------------------------------------------------------------------------------
| |  | /s/AMY E. MILESAmy E. Miles
Chief Financial Officer
March 26, 2008              

---



QuickLinks
**Exhibit 32**

 

**Written Statement of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)**

 

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Regal Entertainment Group, a Delaware corporation (the “Company”), each hereby certifies that, to his/her knowledge on the date hereof:

 

(a) the Form 10-K/A Amendment No. 1 of the Company for the fiscal year ended December 26, 2013, filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
|   | /s/ AMY   E. MILES   |
|--------|---------------------------|
|   | Amy   E. Miles            |
|   | *Chief Executive Officer* |
|   | March 14,   2014     |
|   |                      |
|   | /s/ DAVID   H. OWNBY |
|   | David   H. Ownby          |
|   | *Chief Financial Officer* |
|   | March 14,   2014     |

 

----
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-7409

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

DENNIS CARL HARRIS,

Defendant - Appellant.

No. 06-7410

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

ALFRED CALDWELL, a/k/a Big Al,

Defendant - Appellant.

Appeals from the United States District Court for the Eastern

District of Virginia, at Norfolk. Henry Coke Morgan, Jr., Senior

District Judge. (2:92-cr-00113-01; 2:92-cr-00113-03)

Submitted: July 31, 2007 Decided: August 14, 2007

Before MICHAEL, MOTZ, and KING, Circuit Judges.
- 2 -

Affirmed by unpublished per curiam opinion.

Dennis Carl Harris, Alfred Caldwell, Appellants Pro Se. Laura

Marie Everhart, Assistant United States Attorney, Norfolk,

Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
- 3 -

PER CURIAM:

In these consolidated appeals, Dennis Harris and Alfred

Caldwell appeal the district court’s orders denying their motions

for modification of their sentences, filed pursuant to 18 U.S.C.

§ 3582(c)(2) (2000), and denying reconsideration of those orders.

We have reviewed the record and find the district court did not

abuse its discretion in denying the motions. Accordingly, although

we grant Appellants’ motions to proceed in forma pauperis, we

affirm for the reasons stated by the district court. United States

v. Harris, No. 2:92-cr-00113-01 (E.D. Va. May 19, 2006; July 31,

2006); United States v. Caldwell, No. 2:92-cr-00113-03 (E.D. Va.

May 19, 2006; July 20, 2006). We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

AFFIRMED
#### Linda C. Waterman *v.*United Caribbean, Inc., et al.

The plaintiff’s petition for certification for appeal from the Appellate Court, 20 Conn. App. 283, is granted, limited to the following issue:

> “Did the Appellate Court err in concluding that a trial court may properly render judgment beyond the 120 *814day period allowed by Connecticut General Statutes § 51-183b without the waiver or consent of all parties prior to rendition of the judgment?”

*Haden P. Gerrish,*in support of the petition.

*Paul L. Bollo,*in opposition.

Decided January 11, 1990
#### Julio TAPIA; Edith Tapia, Plaintiffs-Appellants, v. U.S. BANK, N.A., as trustee for RFMSI 2006S3; RFMSI Series 2006-S3 Trust; Homecomings Financial LLC; GMAC Mortgage LLC; Countrywide Home Loans, Incorporated; Bank of America, NA; Ltd Financial Services; United Guaranty Residential Insurance Company of North Carolina; Residential Funding Company, LLC; Mortgage Electronic Registration System, Incorporated; Samuel I. White, P.C.; John & Jane Doe Certificate Holders of RFMSI, Mortgage Backed Certificates, I-M; Jack & Jill Certificate Holders, I-M; Qui & Chi Doe, Associations, Corporations and Entities, I-M, Defendants-Appellees, and First Savings Mortgage Corporation; Larry F. Pratt, Defendants.

No. 10-1856.

United States Court of Appeals, Fourth Circuit.

Submitted: July 28, 2011.

Decided: Aug. 1, 2011.

Christopher E. Brown, R. Michael Smith, Brown, Brown & Brown, P.C., Alexandria, Virginia, for Appellants. John C. Lynch, Troutman Sanders, LLP, Virginia Beach, Virginia, Jon S. Hubbard, Troutman Sanders, LLP, Richmond, Virginia; W. Paul Childress, III, Harry Marge-rum Johnson, III, Hunton & Williams, LLP, Richmond, Virginia, for Appellees.

Before WILKINSON, KEENAN, and DIAZ, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Julio and Edith Tapia appeal from the district court’s final judgment entered after the district court granted Defendants’ Fed.R.Civ.P. 12(b)(6) motions to dismiss Plaintiffs’ state law claims for declaratory judgment, breach of fiduciary duty, and quiet title, as well as their claim under the Fair Debt Collection Practices Act, 15 U.S.C.A. §§ 1692-1692p (West 2009 & Supp.2011). We have reviewed the record and find no reversible error. Accordingly, we affirm the district court’s final judgment. *See Tapia v. U.S. Bank, N.A.,*No. 1:09-cv-01025-GBL-JFA (E.D. Va. filed June 30, 2010; entered July 1, 2010); *see also Horvath v. Bank of N.Y., N.A.,*641 F.3d 617 (4th Cir.2011). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
<PAGE>

                                  EXHIBIT 32.1

                        CERTIFICATION OF PERIODIC REPORT


I, Marvin Rounick, President and Chief Executive Officer of Deb Shops, Inc. (the
"Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350, that:

     (1) the Quarterly Report on Form 10-Q of the Company for the quarterly
period ended July 31, 2005 (the "Report") fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m
or 78o(d)); and

     (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



Date: September 7, 2005





                                          Marvin Rounick
                                          --------------
                                          Marvin Rounick
                                          President and Chief Executive Officer
---

Exhibit 32.1

CERTIFICATION PURSUANT TO 
  18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual
  report of Argentex Mining Corporation (the “Company”) on Form 10-KSB
  for the period ending January 31, 2005 as filed with the Securities and Exchange
  Commission on the date hereof (the “Report”), I, Chris Dyakowski,
  Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section
  906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and                          
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|   

A signed original of this written
  statement required by Section 906 has been provided to Argentex Mining Corporation
  and will be retained by Argentex Mining Corporation and furnished to the Securities
  and Exchange Commission or its staff upon request.

|Date: May 13, 2005 | By: /s/ CHRIS DYAKOWSKI
|------------------ | -----------------------
|                   | Chris Dyakowski        
|                   | Chief Executive Officer

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF AVATEX CORPORATION FOR THE NINE
MONTHS ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          29,246
<SECURITIES>                                       383
<RECEIVABLES>                                    2,832
<ALLOWANCES>                                        27
<INVENTORY>                                          0
<CURRENT-ASSETS>                                33,288
<PP&E>                                          32,420
<DEPRECIATION>                                   2,252
<TOTAL-ASSETS>                                 115,769
<CURRENT-LIABILITIES>                            5,804
<BONDS>                                         33,927
<PREFERRED-MANDATORY>                          235,871
<PREFERRED>                                          0
<COMMON>                                        69,032
<OTHER-SE>                                   (241,239)
<TOTAL-LIABILITY-AND-EQUITY>                   115,769
<SALES>                                          7,544
<TOTAL-REVENUES>                                 7,544
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,699
<INCOME-PRETAX>                                (5,965)
<INCOME-TAX>                                        39
<INCOME-CONTINUING>                            (6,004)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,004)
<EPS-PRIMARY>                                   (1.95)
<EPS-DILUTED>                                   (1.95)
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 01-7792

ROBERT WEARING,

Plaintiff - Appellant,

versus

WILLIAM A. SHELTON, DR., Physician of Institution; ANNE CRUTCHFIELD PHILLIPS, LPN,

Institution Nurse; PATRICIA ANN PEARSON, LPN,

Institution Nurse,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern

District of Virginia, at Alexandria. James C. Cacheris, Senior

District Judge. (CA-01-789-AM)

Submitted: February 14, 2002 Decided: February 26, 2002

Before WIDENER, LUTTIG, and GREGORY, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Robert Wearing, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Robert Wearing, a Virginia inmate, appeals the district

court’s order denying relief on his 42 U.S.C.A. § 1983 (West Supp.

2001) complaint under 28 U.S.C.A. § 1915A (West Supp. 2001) for

failure to state a claim upon which relief may be granted. We have

reviewed the record and the district court’s opinion and find that

this appeal is frivolous. Accordingly, we dismiss the appeal on

the reasoning of the district court. Wearing v. Shelton, No. CA01-789-AM (E.D. Va. filed Sept. 26, 2001; entered Sept. 27, 2001).

We further deny Wearing’s motion for appointment of counsel on

appeal. We dispense with oral argument because the facts and legal

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

DISMISSED